Skip to main content
OpenTrials
Completed

NCT Number: NCT04181840

Impedance Spectroscopy for Obstetric Anal Sphincter Injuries Detection

The main purpose of the study is to evaluate the effectiveness and safety of the impedance spectroscopy device prototype in the detection of anal sphincter injuries in women in the early postpartum period. The study is prospective. The study group comprises up to 56 patients; up to 16 weeks from a natural delivery. The planned participation of each patient in the study is up to 4 weeks and two visits will take place at that time.

After obtaining written consent, at the first visit (V1) each patient will undergo a physical examination (both proctological and gynecological examination), blood samples for laboratory tests and stool samples for calprotectin concentration assessment will be collected. The presence of clinical symptoms of both gas and stool incontinence will be assessed during the visit with the use of Wexner's scale. Then, the dates of two reference tests will be planned: Trans-rectal USG and Recto-anal manometry which will be performed as part of the V1 visit within a period not exceeding 27 days.

The V2 visit, which will also be the final visit, will include a reassessment of the patient's general condition, recording the values of basic vital parameters, subjective and physical examination, and then the doctor conducting the examination will finally determine the extent of sphincter damage, present the patient with therapeutic options and decide on the treatment or rehabilitation of sphincter.

During the visits, all adverse events will also be monitored, both those reported by patients and those related to the examined diagnostic device.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obstetric Anal Sphincter Injury Delivery Complication Obstetric Complication

Age range

18 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Praktyka Lekarska Małgorzata Uchman-Musielak

Warsaw, Masovian Voivodeship, 05-077, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women patients,
  • 18-49 years old,
  • up to 16 weeks from a natural delivery
  • with the presence of:
  • clinically confirmed OASIS at least stage II, as a result of an episiotomy or uncontrolled crotch rupture (in patients with crotch protection), or
  • at least one risk factor, such as:
  • the extended second delivery phase,
  • instrumental delivery (vacuum or forceps),
  • shoulder dystocia,
  • birth weight of the child > 4kg,
  • episiotomy,
  • uncontrolled perineal laceration (in patients with crotch protection),
  • induction of delivery using oxytocin,
  • head circumference ≥34 mm and other.
  • the patient's understanding of the nature of the clinical study and permission in writing from the patient to participate in this study.

Exclusion criteria

  • the presence of acute diseases during treatment,
  • the presence of chronic diseases not treated or treated insufficiently (e.g., incorrectly controlled hypertension),
  • the presence of diseases with accompanying symptoms of fecal incontinence history of proctology surgery's whit postoperative complication,
  • the presence of inflammatory bowel diseases during the exacerbation phase,
  • the treatment in the last year because of serious, progressive, uncontrolled cardiological, pulmonary, nephrology, contagious or psychiatric illness whose course could affect the patient's risk increase due to participation in the study,
  • significant disease symptoms so far undiagnosed,
  • the presence or suspected malignant disease or previous on previous oncological treatment in the last 5 years,
  • the presence of a cardiac stimulator or cardioverter-defibrillator,
  • severe surgery or severe trauma in the last year.

Treatment and study plan

Blood and faeces tests

Diagnostic Test

During V1 - Laboratory tests, particularly for calprotectin concentration assessment

Impedance spectroscopy test

Device

During V1 - the electrical impedance of anal sphincter muscles will be measured

Full gynecological and proctological examination

Diagnostic Test

During V1 and V2 - Examination with a gynecological speculum, Two-handed examination, Rectal examination, and Anoscopy

Transanal ultrasonography

Diagnostic Test

During V1 - reference diagnostic methods with documented effectiveness and safety; for comparison with impedance spectroscopy results.

Anorectal manometry

Diagnostic Test

During V1 - reference diagnostic methods with documented effectiveness and safety; for comparison with impedance spectroscopy results.

Determining the degree of sphincter injury

Other

During V2 - conducting the examination will finally determine the extent of sphincter damage, present the patient with therapeutic options and decide on the treatment or rehabilitation of sphincter.

Primary outcomes

  1. Anal sphincters continuity (injuries) assessed in physical examination and trancanal ultrasonography

    Time frame: 16 weeks

    Assessment using:

    • OASIS classification of perineal tears.
    • Starck scale (0-16 scale, no defect - 0, maximum - 16, which means severe damage of both sphincters on a considerable length and circumference).
    • Norderval scale (0-7 scale, no defect - 0, 7 is the maximal damage of both anal sphincters).

  2. Anal sphincter tension (function) assessed in physical examination and anorectal manometry

    Time frame: 16 weeks

  3. Anal sphincter assessment evaluated by impedance spectroscopy

    Time frame: 16 weeks

    Estimation of the presence, extent and severity of anal sphincter injury, by impedance moduli and phase shifts.

    The main aim of the study is to establish whether the extension and severity of obstetric anal sphincter injury can be precisely assessed with parameters calculated from anal sphincter muscles using impedance spectroscopy.

Secondary outcomes

  1. Adverse events

    Time frame: 16 weeks

    Evaluation of the frequency and intensity of adverse events associated with the use of the new diagnostic method.

Sponsors and collaborators

Lead sponsor

OASIS Diagnostics S.A.

Industry

Registry information

Official study title

Impedance Spectroscopy Using the ONIRY Device in the Diagnosis of Sphincter Injuries in Women After Vaginal Deliveries

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Dec 2, 2019
Registry last updated
Sep 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.